Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
advanced malignant solid tumor, neoantigen, neoantigen reactive t cells (nrts), pd-1 inhibitor, advanced solid tumor, adoptive cell therapy(act), pd-1 antibody, shr1210, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 863322
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.